Wednesday, April 8, 2026
Wednesday, April 8, 2026
9.1 C
New York
- Advertisement -spot_img

TAG

Kite

New ASH 2025 Data Show Yescarta® Provides Strong and Reliable Outcomes for Hard-to-Treat Lymphoma Patients

New research presented at ASH 2025 shows that Yescarta® continues to deliver reliable results for patients battling relapsed or refractory large B-cell lymphoma—even for...

Latest news

- Advertisement -spot_img